Osaic Holdings
TNGX icon

Osaic Holdings’s Tango Therapeutics TNGX Stock Holding History

Osaic Holdings’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.89K Sell
425
-267
-39% -$3.72K ﹤0.01% 6372
2025
Q4 		$6.13K Buy
692
+101
+17% +$870 ﹤0.01% 6584
2025
Q3 		$4.99K Buy
591
+91
+18% +$616 ﹤0.01% 6745
2025
Q2 		$2.56K Buy
+500
New +$1.24K ﹤0.01% 6847
2025
Q1 		– Sell
-330
Closed -$1.02K – 7705
2024
Q4 		$1.02K Sell
330
-371
-53% -$1.72K ﹤0.01% 6841
2024
Q3 		$5.4K Sell
701
-1,745
-71% -$16.7K ﹤0.01% 6154
2024
Q2 		$21K Buy
+2,446
New +$18.9K ﹤0.01% 5313

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Osaic Holdings's TNGX Position: Q1 2026 in Review

Osaic Holdings reduced its Tango Therapeutics (TNGX) stake by 39% in Q1 2026, selling an estimated $3.72K and leaving 425 shares worth $8.89K. The position accounts for ﹤0.01% of the portfolio, ranked #6372.

Osaic Holdings first reported a position in TNGX in Q2 2024 and has held it in 7 quarters since. The position peaked at $21K in Q2 2024. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Osaic Holdings held 425 shares of Tango Therapeutics worth $8.89K as of Q1 2026.
  • Osaic Holdings sold 267 Tango Therapeutics shares in Q1 2026, an estimated $3.72K.
  • Tango Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6372 holding.
  • Osaic Holdings first reported a position in Tango Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • Osaic Holdings's Tango Therapeutics position peaked at $21K in Q2 2024.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.